CAMBRIDGE, Mass., June 21 /PRNewswire-FirstCall/ --
Biogen, Inc. (Nasdaq: BGEN) announced today that its presentation at the
William Blair & Company Growth Stock Conference will be webcast live on
Tuesday, June 25, 2002. The presentation begins at 2:10 pm (EDT) and can be
accessed through Biogen's homepage, http://www.Biogen.com.
(Photo: http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO )
About Biogen
Biogen, Inc., winner of the U.S. National Medal of Technology, is a
biotechnology company principally engaged in discovering and developing drugs
for human healthcare through genetic engineering. Headquartered in Cambridge,
MA, the Company's revenues are generated from worldwide sales of AVONEX(R)
(interferon beta-1a) for treatment of relapsing forms of multiple sclerosis
(please see full prescribing information at http://www.avonex.com), and from
the sales by licensees of a number of products. Biogen's research and
development activities are focused on novel products to treat inflammatory and
autoimmune diseases, neurological diseases, cancer, fibrosis and congestive
heart failure.
SOURCE Biogen, Inc.
 back to top
Related links:
http://www.biogen.com
Company News On-Call:
http://www.prnewswire.com/comp/101550.html
Photo Notes:
NewsCom:
http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840
CONTACT:
Rob Jacobson of Biogen, +1-617-679-3710
|
